基本信息

• 商品名稱：藥理學(留學生與雙語教學用英文版全國高等醫藥院校規劃教材)
• 作者：編者:婁建石
• 代碼：79.8
• 出版社：清華大學
• ISBN號：9787302384830

其他參考信息

• 出版時間：2015-07-01
• 印刷時間：2015-07-01
• 版次：1
• 印次：1
• 開本：16開
• 包裝：平裝
• 頁數：381
• 字數：671千字

內容提要

婁建石主編的《藥理學（留學生與雙語教學用英 文版）》繫統地介紹了藥理學的基本知識，包括常用 藥物的作用和原理、臨床應用、不良反應以及藥物相 互作用等。內容簡明易懂，適合臨床醫學專業學生初 步學習藥理學的入門教材，也可作為其他醫學相關專 業學生學習藥理學的教材，如護理學、口腔醫學、麻 醉學、中西醫結合醫學、醫學檢驗、醫學影像、公共 衛生和藥學專業等。本書也可供醫藥衛生專業工作人 員學習和應用藥理學的參考教材。
    

目錄

Chapter 1 Introduction
I. Development of Pharmacology
II. New Drug Research
Chapter 2 Pharmacodynamics
I. General Classification of Drug Effects
II. Dose-Effect Relationship
III. Receptor Theory and Drug Receptor Interaction
IV. Receptor Families and Their Transducer and Effector Molecules
V. Relationship Between Regulatory Mechanisms of Receptors and the Pharmacological Action
VI. Mechanism of Action
Chapter 3 Pharmacokinetics
I. Drug Transport across Membranes
II. The Dynamics of Drug Absorption, Distribution, and Elimination
II. General Principles of Pharmacokinetics
Chapter 4 Pharmacogenetics
I. The Objectives of Research in Pharmacogenetics
II. The Effect of Genetic Factors on Drug Reactions
III. The Racial Difference of Drug Reaction and Metabolism
Chapter 5 Autonomic Pharmacology
I. Anatomy and Neurotransmitter Chemistry of the Autonomic Nervous System
II. Biosynthesis and Metabolism of Transmitters
III. Locations of Autonomic Receptors
IV. Presynaptic Regulation of Transmitter Release
V. Functional Organization of Autonomic Activity
VI. Coupling Mechanism of Receptor-effect
VII. Mode of Action of Autonomic Nervous System Drugs
VIII. Classification of Autonomic Nervous System Drugs
Chapter 6 Cholinoceptor-Activating and Cholinesterase-lnhibiting Drugs
I. Direct-acting Cholinoceptor Stimulants
II. Cholinesterase Inhibitors
Chapter 7 Organophosphates Anticho:inesterase Intoxication and Cholinesterase Reactivators...
I. Organophosphates Anticholinesterase Intoxication
II. Cholinesterase Reactivator
Chapter 8 M CholinoceptorAntagonists
I. Natural M Cholinoceptor Blocking Drugs
II. Synthetic Spasmolytic Drugs
Chapter 9 N CholinoceptorAntagonists
I. N1 Cholinoceptor Blocking Drugs
II. N2 Cholinoceptor Blocking Drugs
Chapter 10 Adrenoceptor-Activating Drugs
I. Chemical Structure
II. Classification
III. Mixed α and β Receptor Agonists
IV. α Receptor Agonists
V. β Receptor Agonists
VI. Dopaminergic Receptor Agonists
Chapter 11 Adrenoceptor Blocking Drugs
I. a Receptor Antagonists
II. β Receptor Antagonists
III. a, β Receptor Antagonists
Chapter 12 Sedative-Hypnotics Drugs
I. Introduction
II. Benzodiazepines
III. Barbiturates
IV. Other Sedative-Hypnotics
Chapter 13 Antiepileptic Drugs
I. Classification of Seizure Types
II. Drugs Used in Seizures
III. Selectivity and Withdrawal of Antiepileptic Drugs
IV. Anticonvulsant Drugs
Chapter 14 Psychotropic Drugs
I. Antipsychotic Drugs
II. Antimanic Drugs
III. Antidepressants
Chapter 15 Antiparkinsonism Drugs
I. Dopaminergic Drugs
II. Anticholinergic Drugs
III. Others
Chapter 16 Antipyretic-Analgesic and Antiinflammatory Drugs
I. Introduction
II. Salicylates
III. Anilines
IV. Pyrazolones
V. Others
VI. Analgesic Compounds
VII. Slow Acting Antirheumatic Drugs
VIII. Antigout Drugs
Chapter 17 Narcotic Analgesics
I. Introduction
II. Opioid Receptor Agonists
III. Opioid Receptor Antagonists
Chapter 18 Central Stimulants
I. Cerebral Stimulants
II. Medullary Stimulants
Chapter 19 Drugs Used in the Treatment of Heart Failure
I. Pathophysiology of Congestive Heart Failure
II. Diuretics
lII. Aldosterone Antagonists
IV. Inhibitors of RAAS: ACEI and AT1 Receptor Antagonists
V. β Adrenergic Receptor Blocking Agents
VI. Vasodilators
VII. Cardiac Glycosides
VS. [3 Adrenergic Receptor Stimulators
IX. Phosphodiesterase Inhibitors
Chapter 20 Antihypertensive Drugs
|. Introduction
II. Drugs that Alter Sodium and Water Balance
Ill. Drugs that Alter Sympathetic Nervous System Function
IV. Vasodilators
V. Drugs that Interfere with the Renin-Angiotensin System
VI. Clinical Pharmacology of Antihypertensive Drugs
Chapter 21 Anti-Angina Pectoris Drugs
I. Introduction
II. Nitrates and Nitrites
III. Calcium Channel Blockers
IV. /3 Receptor Antagonists
Chapter 22 Antiarrhythmic Drugs
I. Introduction
II. Class I A
III. Class I B
IV. Class I c
V. Class II
VI. Class III
VII. Class IV
VIII. Others
Chapter 23 Autihyperlipidemic Drugs
I. Atherogenesis
II. Lipoprotein Transport
III. Dyslipidaemia
IV. Antihyperlipidemic Drugs
Chapter 24 Diuretic and Dehydrant Drugs
I. Kidney Structure and Function
II. Diuretics
III. Osmotic Diuretics (Mannitol, Sorbitol, Glucose, Urea)
Chapter 25 Antiasthmatie Drugs
I. Bronchodilators
II. Anti-Inflammatory Drugs
Chapter 26 Drugs Used in Gastrointestinal Diseases
I. Drugs Used to Treat Peptic Ulcer
1I. Antiemetic Drugs
III. Antidiarrheal Drugs
IV. Laxatives.
Chapter 27 Drugs Affecting Uterine Motility
I. Drugs that Stimulate Uterine Contraction
II. Drugs that Inhibit Uterine Contraction
Chapter 28 Anticoagulants and Coagulants
I. Introduction
II. Anticoagulants
III. Antiplatelet Drugs
IV. Fibrinolytic Drugs
V. Coagulants
Chapter 29 Histamine and Antihistamine Drugs
I. Histamine
II. H1 Receptor Antagonists
III. H2 Receptor Antagonists
Chapter 30 Adrenocorticosteroids
I. Introduction
II. Glucocorticoids
III. Mineralocorticoids
Chapter 31 Drugs Affecting the Thyroid Gland
I . Thyroid Hormone (TH)
II. Antithyroid Drugs
Chapter 32 Antidiabetic Drugs
I. Insulin
II. Oral Hypoglycemic Drugs
III. Current Treatment Options
Chapter 33 Introduction to Antibacterial Drugs
I. Specialty Terms
H. Antimicrobial Mechanisms
III. Mechanism of Resistance to Antibiotics
Chapter 34 SyntheticAntimicrobial Drugs
I. Sulfonamides
II. Trimethoprim
III. Quinolones
Chapter 35 β-Lactam Antibiotics
I. Penicillins
II. Cephalosporins
III. Other β-Lactam Drugs
Chapter 36 Macrolides, Lincosamides and Glycopeptides
I. Macrolides
II. Lincosamides
III. Glycopeptides
Chapter 37 Broad-Spectrum Antibiotics
I. Tetracyclines
II. Chloramphenicols
Chapter 38 Aminoglycosides and Polypeptides
I. Aminoglycosides
II. Polypeptides
Chapter 39 Antifungal Drugs
I. Antibiotics
II. Azole Antifungal Drugs
11I. Allylamine Antifungal Drugs
IV. Pyrimidine Antifungal Drugs
Chapter 40 Antiviral Drugs
I. Anti-Human Immunodeficiency Virus Drugs
II. Anti-Herpersvirus Drugs
III. Anti-Influenza Drugs
IV. Anti-Hepacivirus Drugs
Chapter 41 Antimycobacterial Drugs
I. Introduction
II. First-Line Drugs Used in Tuberculosis
III. Alternative Second-Line Drugs in Treatment of Tuberculosis
IV. Combination Chemotherapy of Tuberculosis
Chapter 42 Antimalarial Drugs
I. Plasmodium Life Cycles and Action of Antimalarial Drugs
II. Antimalarial Drugs Mainly Applied to Control Symptoms
III. Antimalarial Drugs Mainly Applied to Control Relapse and Transmission
IV. Antimalarial Drugs Mainly Applied to Causal Prophylaxis
Chapter 43 Amebicides
I. Life Cycles of Entamoeba Histolytica and Action of Amebicides
II. Luminal Amebicides
III. Extraintestinal Amebicides
IV. Luminal and Simultaneously Extraintestinal Amebicides
Chapter 44 Anthelmintic Drugs
I. Nematocides
II. Taeniacides
III. Anti-Trematode Drugs
Chapter 45 Antineoplastic Drugs
I. Introduction
II. Cytotoxic Drugs
III. Non-Cytotoxic Drugs
References